Literature DB >> 18771930

11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.

Wei Feng1, Mavurapu Satyanarayana, Yuan-Chin Tsai, Angela A Liu, Leroy F Liu, Edmond J LaVoie.   

Abstract

Several 11-substituted benzo[i]phenanthridine derivatives were synthesized, and their TOP1-targeting activity and cytotoxicity were assessed. Comparative data indicate that TOP1-targeting was often the primary molecular target associated with their cytotoxicity. Several 11-aminoalkyl derivatives, 11-aminocarboxy derivatives as well as the 11-[(2-dimethylamino)ethyl]carboxamide of 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine were synthesized and did exhibit considerable cytotoxicity with IC(50) values ranging from 20 to 120 nM in the human lymphoblast tumor cell line RPMI8402.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771930      PMCID: PMC2733853          DOI: 10.1016/j.bmc.2008.08.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  31 in total

1.  Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation.

Authors:  H Wang; Y Mao; A Y Chen; N Zhou; E J LaVoie; L F Liu
Journal:  Biochemistry       Date:  2001-03-20       Impact factor: 3.162

Review 2.  Tumor cell death induced by topoisomerase-targeting drugs.

Authors:  T K Li; L F Liu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 3.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 4.  Cellular roles of DNA topoisomerases: a molecular perspective.

Authors:  James C Wang
Journal:  Nat Rev Mol Cell Biol       Date:  2002-06       Impact factor: 94.444

5.  BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells.

Authors:  C H Yang; E Schneider; M L Kuo; E L Volk; E Rocchi; Y C Chen
Journal:  Biochem Pharmacol       Date:  2000-09-15       Impact factor: 5.858

6.  Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.

Authors:  S Kawabata; M Oka; K Shiozawa; K Tsukamoto; K Nakatomi; H Soda; M Fukuda; Y Ikegami; K Sugahara; Y Yamada; S Kamihira; L A Doyle; D D Ross; S Kohno
Journal:  Biochem Biophys Res Commun       Date:  2001-02-09       Impact factor: 3.575

7.  Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Authors:  R W Robey; W Y Medina-Pérez; K Nishiyama; T Lahusen; K Miyake; T Litman; A M Senderowicz; D D Ross; S E Bates
Journal:  Clin Cancer Res       Date:  2001-01       Impact factor: 12.531

8.  The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Authors:  C Erlichman; S A Boerner; C G Hallgren; R Spieker; X Y Wang; C D James; G L Scheffer; M Maliepaard; D D Ross; K C Bible; S H Kaufmann
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

Review 9.  Novel mechanisms of drug resistance in leukemia.

Authors:  D D Ross
Journal:  Leukemia       Date:  2000-03       Impact factor: 11.528

10.  Assembly of 4-aminoquinolines via palladium catalysis: a mild and convenient alternative to SNAr methodology.

Authors:  Brandon J Margolis; Kimberly A Long; Dana L T Laird; J Craig Ruble; Shon R Pulley
Journal:  J Org Chem       Date:  2007-02-13       Impact factor: 4.354

View more
  1 in total

1.  A support vector machine classification model for benzo[c]phenathridine analogues with toposiomerase-I inhibitory activity.

Authors:  Khac-Minh Thai; Thuy-Quyen Nguyen; Trieu-Du Ngo; Thanh-Dao Tran; Thi-Ngoc-Phuong Huynh
Journal:  Molecules       Date:  2012-04-17       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.